{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:20:31Z","timestamp":1791267631505,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.cancergencyto.2006.02.001","type":"journal-article","created":{"date-parts":[[2006,9,27]],"date-time":"2006-09-27T11:30:07Z","timestamp":1159356607000},"page":"109-119","source":"Crossref","is-referenced-by-count":33,"title":["Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis"],"prefix":"10.1016","volume":"168","author":[{"given":"Anastasia","family":"Athanasiadou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliki","family":"Tsompanakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gaitatzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Kalogiannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achilles","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Fassas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tsezou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2006.02.001_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1182\/asheducation-2004.1.163","article-title":"Chronic lymphocytic leukemia","author":"Byrd","year":"2004","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/1097-0142(197708)40:2<855::AID-CNCR2820400239>3.0.CO;2-1","article-title":"A clinical staging system for chronic lymphocytic leukemia: prognostic significance","volume":"40","author":"Binet","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib4","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib5","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib6","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Dohner","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib7","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V99.3.1023","article-title":"CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease","volume":"99","author":"Hamblin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib8","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMoa023143","article-title":"ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia","volume":"348","author":"Crespo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood.V100.4.1177.h81602001177_1177_1184","article-title":"Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors","volume":"100","author":"Oscier","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib10","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416","article-title":"V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia","volume":"100","author":"Krober","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/sj.leu.2402537","article-title":"Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course","volume":"16","author":"Stilgenbauer","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib12","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood-2002-06-1801","article-title":"The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression","volume":"101","author":"Ghia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib13","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa040857","article-title":"ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia","volume":"351","author":"Rassenti","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.V82.2.571.571","article-title":"Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology","volume":"82","author":"Que","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib15","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1182\/blood.V81.10.2702.2702","article-title":"Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia","volume":"81","author":"Escudier","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib16","first-page":"212","article-title":"Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia","volume":"84","author":"Liso","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2141.1997.402686.x","article-title":"Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases","volume":"97","author":"Criel","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib18","first-page":"602","article-title":"Trisomy 12 and lymphoplasmacytoid lymphocytes in chronic leukemic B-cell disorders","volume":"83","author":"Hjalmar","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib19","first-page":"174","article-title":"Sequential fluorescence in situ hybridization analyses for trisomy 12 in chronic leukemic B-cell disorders","volume":"86","author":"Hjalmar","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0165-4608(03)00136-5","article-title":"Interphase cytogenetic analysis in Argentinean B-cell chronic lymphocytic leukemia patients: association of trisomy 12 and del(13q14)","volume":"146","author":"Chena","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1365-2141.1996.d01-1478.x","article-title":"Trisomy 12 defines a group of CLL with atypical morphology: Correlation between cytogenetic, clinical and laboratory features in 544 patients","volume":"92","author":"Matutes","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2141.1998.00661.x","article-title":"Trisomy 12 is seen within a specific subtype of B-cell chronic lymphoproliferative disease affecting the peripheral blood\/bone marrow and co-segregates with elevated expression of CD11a","volume":"101","author":"Su'ut","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib23","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","article-title":"National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment","volume":"87","author":"Cheson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0165-4608(98)00150-2","article-title":"PHA\/IL2: an efficient mitogen cocktail for cytogenetic studies of non-Hodgkin lymphoma and chronic lymphocytic leukemia","volume":"109","author":"Morgan","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib25","article-title":"An international system for human cytogenetic nomenclature","author":"ISCN","year":"1995"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib26","doi-asserted-by":"crossref","unstructured":"Smilevska T, Stamatopoulos K, Samara M, Belessi C, Tsompanakou A, Paterakis G, Stavroyianni N, Athanasiadou I, Chiotoglou I, Hadzidimitriou A, Athanasiadou A, Douka V, Saloum R, Laoutaris N, Anagnostopoulos A, Fassas A, Stathakis N, Kollia P. Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemia. Leuk Res 2005 Jul 27; [Epub ahead of print].","DOI":"10.1016\/j.leukres.2005.06.006"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib27","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1182\/blood-2004-07-2606","article-title":"Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene","volume":"105","author":"Ghia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib28","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1182\/blood-2005-04-1511","article-title":"Immunoglobulin light chain repertoire in chronic lymphocytic leukemia","volume":"106","author":"Stamatopoulos","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib29","unstructured":"Lefranc M.-P. IMGT databases, web resources and tools for immunoglobulin and T cell receptor sequence analysis, http:\/\/imgt.cines.fr. Leukemia 2003;17:260\u2013266."},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib30","doi-asserted-by":"crossref","first-page":"D593","DOI":"10.1093\/nar\/gki065","article-title":"IMGT, the international ImMunoGeneTics information system","volume":"33","author":"Lefranc","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib31","doi-asserted-by":"crossref","first-page":"W435","DOI":"10.1093\/nar\/gkh412","article-title":"IMGT\/V-QUEST, an integrated software for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis","volume":"32","author":"Giudicelli","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/10428190400011591","article-title":"Report of two novel chromosomal translocations in chronic lymphocytic leukemia","volume":"46","author":"Athanasiadou","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cancergencyto.2004.08.012","article-title":"The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia","volume":"158","author":"Glassman","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib34","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1080\/10428190410001680546","article-title":"Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"45","author":"Aoun","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1365-2141.1996.d01-1492.x","article-title":"Trisomy 12 and structural abnormalities of 13q14 occurring in the same clone in chronic lymphocytic leukaemia","volume":"92","author":"Mould","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib36","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1182\/blood.V89.11.4153","article-title":"Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities","volume":"89","author":"Oscier","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib37","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1046\/j.1365-2141.1998.00891.x","article-title":"Association and clonal distribution of trisomy 12 and 13q14 deletions in chronic lymphocytic leukaemia","volume":"102","author":"Navarro","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib38","first-page":"2003","article-title":"Karyotypic evolution in CLL: identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease","volume":"9","author":"Fegan","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1096-8652(199811)59:3<223::AID-AJH7>3.0.CO;2-Y","article-title":"Secondary abnormalities of chromosome 6q in B-cell chronic lymphocytic leukemia: a sequential study of karyotypic instability in 51 patients","volume":"59","author":"Finn","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib40","doi-asserted-by":"crossref","first-page":"561","DOI":"10.5858\/2003-127-0561-CEICLL","article-title":"CD79b expression in chronic lymphocytic leukemia. Association with trisomy 12 and atypical immunophenotype","volume":"127","author":"Schlette","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/cyto.990220309","article-title":"Clinical, biological, and immunophenotypical characteristics of B-cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridization","volume":"22","author":"Tabernero","year":"1995","journal-title":"Cytometry"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0145-2126(97)00169-0","article-title":"Trisomy 12 in chronic lymphocytic leukemia\u2013geographical variation","volume":"22","author":"Nair","year":"1998","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.GIM.0000105741.57923.08","article-title":"A set of commercially available fluorescent in-situ hybridization probes efficiently detects cytogenetic abnormalities in patients with chronic lymphocytic leukemia","volume":"6","author":"Goorha","year":"2004","journal-title":"Genet Med"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib44","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors","volume":"102","author":"Fais","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib45","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1146\/annurev.immunol.21.120601.141018","article-title":"B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor","volume":"21","author":"Chiorazzi","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cancergencyto.2006.02.001_bib46","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1182\/blood-2003-12-4312","article-title":"Chronic lymphocytic leukemia: revelations from the B-cell receptor","volume":"103","author":"Stevenson","year":"2004","journal-title":"Blood"},{"issue":"Suppl","key":"10.1016\/j.cancergencyto.2006.02.001_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/10428199109103374","article-title":"Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Second IWCCLL compilation of data on 662 patients","volume":"5","author":"Juliusson","year":"1991","journal-title":"Leuk Lymphoma"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460806000720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460806000720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T16:09:51Z","timestamp":1627834191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460806000720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0165460806000720"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2006.02.001","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}